Medical diagnostic device company Welch Allyn acquired Omaha, Nebraska-based HealthInterlink, which makes software-based remote patient vital signs monitoring solution that is FDA 510(k) cleared for marketing in the U.S.

HealthInterlink’s telehealth solution incorporates wireless patient monitoring devices and a mobile gateway device such as tablet or smartphone that transmits vital signs data, answers to patient care plan questions, and patient messages to a HIPAA-compliant cloud-based web portal for patient data management by healthcare professionals and other authorized stakeholders. The company’s software and telehealth expertise coupled with Welch Allyn’s sales, marketing, and customer support strength will give clinicians a powerful tool to manage more patients outside traditional healthcare settings.

“The acquisition of the HealthInterlink assets offers Welch Allyn a unique opportunity to better serve its U.S. customers by offering them an mHealth solution optimized for cost-effective collection and delivery of remote health information,” said Stephen Meyer Welch Allyn President and CEO.

During a transition period, HealthInterlink’s current product will continue to be developed, sourced and sold by HeatlhInterlink’s existing workforce.During a transition period, HealthInterlink’s current product will continue to be developed, sourced and sold by HealthInterlink’s existing workforce. It will be business as usual for all HealthInterlink partners and customers while the integration and transition is underway.

According to a report published by the Centers for Disease Control and Prevention, chronic diseases and conditions like hypertension, heart disease, stroke, diabetes, chronic obstructive pulmonary disease (COPD), and obesity are among the most common, costly, and preventable of all health problems. Remote patient monitoring solutions such as those made by HealthInterlink help tackle this problem, reducing the cost of chronic disease management.

Terms of the deal were not announced.